Basel, Switzerland

Xavier Lucas

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xavier Lucas. Retrieved from https://idiyas.com/inventor/xavier-lucas-ho49orn8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xavier Lucas: Innovator in Pharmaceutical Chemistry

Introduction

Xavier Lucas is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that focus on innovative compounds with potential medicinal applications.

Latest Patents

Lucas's latest patents include the development of pyrazoleamide derivatives. This invention provides compounds of formula I or II, wherein X, R, and R are as described in the patent, along with pharmaceutically acceptable salts. Additionally, the invention addresses the manufacture of these compounds, pharmaceutical compositions comprising them, and their use as medicaments. Another significant patent involves sulfone derivatives, which also presents compounds of formula I.

Career Highlights

Xavier Lucas is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on creating innovative solutions that can enhance therapeutic options for various medical conditions.

Collaborations

Lucas has collaborated with esteemed colleagues such as Patrizio Mattei and Dmitry Mazunin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Xavier Lucas stands out as a dedicated inventor in the pharmaceutical sector, with a focus on developing compounds that hold promise for future medical applications. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…